Chris Ogden | executive |
Sean McCarthy | executive |
Joseph Catanzaro | analyst |
Malcolm Kuno | analyst |
Good day, and thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker for today, Chris Ogden, Senior Vice President, Finance and Accounting, please go ahead.
Thank you.